Labcorp Completes Millennium Health Acquisition to Expand Toxicology Testing
The deal adds a specialty laboratory focused on drug testing and surveillance to Labcorp's national network.
The deal adds a specialty laboratory focused on drug testing and surveillance to Labcorp's national network.
Abbott has launched a next-generation Oncodetect MRD test that uses whole-genome sequencing to track up to 5,000 patient-specific cancer variants, offering a 30-fold increase in detection sensitivity, according to the company.
CMS has released preliminary 2027 CLFS rates, with data showing weighted median payment cuts for over 1,100 test codes; annual reductions are capped at 15% from 2027 to 2029 under current policy.
The College of American Pathologists has updated 14 Cancer Protocols, mandating the Breast Phyllodes Tumor protocol for accreditation and revising breast biomarker and GIST molecular testing criteria, according to CAP.
A global survey of 231 labs in 41 countries, published by IOF and IFCC, reveals significant inconsistencies in bone biomarker testing methods, reference intervals, and quality assessments, highlighting a need for greater harmonization.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
New software allows researchers to examine repeat expansions associated with up to 23 disease-related genetic regions in a single run.
Urinalysis comparison guide featuring testing capabilities, technology, throughput, connectivity, sample capacity, and key specifications from leading systems.